title: A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV.
authors: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore. colintan_eye@yahoo.com.sg.|Fundus Image Reading Center, National Healthcare Group Eye Institute, Singapore, Singapore. colintan_eye@yahoo.com.sg.
authors: Colin S
authors: CS
authors: Tan
authors: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
authors: Kai Xiong
authors: KX
authors: Cheong
authors: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
authors: Louis W
authors: LW
authors: Lim
authors: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
authors: Shoun
authors: S
authors: Tan
mesh_terms: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization; D006801:Humans; D058449:Intravitreal Injections; D009216:Myopia; D000069579:Ranibizumab; D042461:Vascular Endothelial Growth Factor A; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab